Spotlight Series | Behavioral Health: Past, Present and Future

WEBINAR DESCRIPTION:

The Digital Healthcare Innovation Summit (DHIS) is an unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution. While COVID-19 forced us to postpone this year’s in-person event, we didn’t want the compelling stories that drive our community forward to stop. Until we can meet in person next year, we’re launching the DHIS Spotlight Series. Like the conference, this series will feature discussions (panels or 1-on-1 conversations) that explore relevant topics for digital health innovators and business leaders.

This first episode will feature three exclusive interviews:

11:00 am EPISODE INTRODUCTION: Delphine O'Rourke, JD – Partner, Goodwin

11:05 am KEYNOTE INTERVIEW: The understanding of behavioral health and strategies around it has evolved greatly over the past couple decades. This keynote interview will examine this progress, as well as the role start-up and large companies play in innovation and adoption of behavioral health technology. This conversation will also explore the excitement and capital flowing into this field right now, while raising any potential downsides and offering advice for entrepreneurs who are currently operating or planning to start behavioral health technology companies. Guest: Cara McNulty, DPA – President, Behavioral Health & EAP at Aetna, a CVS Health Company Interviewed by: Dan Gebremedhin, MD, MBA – Partner, Flare Capital Partners

11:30 am ENTREPRENEURS AND START-UP EXECUTIVES PANEL: Reimbursement coverage for behavioral health services hit a milestone in 2008 when Congress passed the Mental Health Parity and Addiction Equity Act (MHPAEA) which required insurers to equalize coverage for behavioral health and medical health benefits in terms of co-pays, deductibles, lifetime caps and access to providers. Fast forward to present day when demand for behavioral health services outpaces the availability of treatment and the COVID-19 pandemic ushers in unprecedented levels of anxiety and isolation. The heightened demand for new service models is driving a shift towards virtual and digital behavioral care and opens tremendous opportunities for innovative start-ups as regulatory and reimbursement barriers diminish. Investors recognize the enormous unmet medical need and opportunity as of late, pumping $588 million into behavior healthtech start-ups in the first half of 2020, according to Rock Health.

Moderator: Dan Gebremedhin, MD, MBA – Partner, Flare Capital Partners

Panelists: Seth Feuerstein, MD, JD, Founder – Oui Health Reena Pande, MD, MSc, Chief Medical Officer – AbleTo Samir Malik, MBA, Executive Vice President and General Manager of Genoa Telepsych, Co-founder 1Docway Corbin Petro, MBA, Co-Founder & CEO - Eleanor Health

12:30 pm DEEP DIVE FIRESIDE CHAT ON CMOs AND WOMEN IN HEALTHTECH: This fireside chat will debrief and dig deeper into some of the topics raised in the previous panel and also focus on some of the unique challenges of transitioning from an academic physician to a healthcare start-up executive, leading as CMO at a behavioral health start-up, and being a woman leader in this industry.

Guest: Reena Pande, MD, MSc, Chief Medical Officer - AbleTo

Interviewed by: Danielle Lauzon, JD – Partner, Goodwin

SPEAKERS’ BIOGRAPHIES:

Delphine O'Rourke Delphine O’Rourke is a partner in the Goodwin’s Life Sciences group and Healthcare practice and is a member of the firm’s Corporate Social Responsibility initiative. She is trusted counsel to health industry leaders. Ms. O’Rourke counsels health companies, hospitals & healthcare systems, and investors on the regulatory frameworks that drive their business. Clients rely on her deep knowledge of healthcare law and policy as well as her experience as a healthcare executive and in-house general counsel. She served as Associate General Counsel of Ascension, and in her decades plus with Ascension, she served in legal roles of increasing responsibility for the $29 billion health enterprise. Ms. O’Rourke is a regular speaker on cutting edge healthcare regulatory developments and contributor to leading legal and industry publications and podcasts including Modern Healthcare, Law360 and the American Health Law Association. She is nationally recognized for her commitment to the advancement of women and inclusionary leadership, and also maintains an active pro bono practice. Ms. O’Rourke earned a JD from Columbia University and BS from Georgetown University.

Cara McNulty Cara McNulty is President of Aetna Behavioral Health, a leading provider of mental health and employee assistance program (EAP) solutions to members around the globe. She oversees a national team that spearheads the development of programs, products and capabilities designed to offer individuals easy access to quality, innovative treatments and meet people along their health care journey, while driving engagement and improving health outcomes through an easy and meaningful experience. Cara previously served as the North American leader of Integrated Wellbeing for Willis Towers Watson. Her responsibilities included advising clients on strategies focusing on employee engagement, clinical outcomes and productivity. She sat on the company’s Health and Benefits Specialty Practice Leadership team and focused on integrated wellbeing, intellectual capital and service development across physical, emotional, financial and social dimensions. She was also previously head of Population Health, Team Member Wellbeing and Guest Wellness for Target Corporation, where she led efforts to implement the company’s health agenda. Cara is nationally recognized for her strategic design and implementation of Minnesota’s transformational population health care legislation, which to date is one of the largest financial allocations in the country for initiatives known to be reducing health disparities and chronic diseases. She holds a doctorate in public administration from Hamline University, a Master of Science in applied health science from Indiana University and a Bachelor of Science in community health education from the University of Minnesota-Duluth.

Dan Gebremedhin Dan Gebremedhin is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Eden Health and Somatus. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician at the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. He has served as a Health Policy Advisor for Massachusetts Governor Charlie Baker and currently sits on the Massachusetts State Board of Nursing Home Administrators. Dan earned a BS from the University of California, San Diego, an MD from the Morehouse School of Medicine, and an MBA from the Harvard Business School.

Seth Feuerstein Seth Feuerstein is a seasoned healthcare executive and is also on the faculty of the Yale School of Medicine Department of Psychiatry. There, he is also the founder and Executive Director of the Center for Digital Health and the Director of Innovation to Impact, as well as on the advisory board of the Yale Center for Biomedical and Interventional Technology. He has overseen and built national care innovation models and has worked to develop, study and scale technologically based innovations to enhance access, data collection, research and care in healthcare including founding and running a behavioral health software form that is now built into more than 100 million benefit lives in the US as well as in other languages and international health systems. This company was acquired by Magellan Health where he served as the Chief Medical and Innovation officer. Considered a global leader in the field of behavioral health innovation, digital health, healthcare innovation and other related fields, he has also been appointed as a senior advisor to the Department of Defense for behavioral health and suicide prevention, the Scientific Advisory Board of NASA’s Translational Research Institute, and the clinical advisory boards of multiple payers. Seth has a variety of additional board roles at digital health companies, is on the board of the State of Connecticut bioscience venture fund, and also serves as a consulting psychiatrist for the Connecticut Department of Mental Health and Addiction Services. He is actively involved in the community, having launched Little Wonder, a non-profit organization that supports cancer patients and their loved ones by leveraging technology to improve their treatment experience with positive non-treatment related events such as concerts and theater to drive improved personal and clinical outcomes. Seth received his bachelor’s degree from Cornell University, his medical and law degrees from New York University, and completed his medical internship and psychiatry residency at Yale University.

Reena Pande As Chief Medical Officer of AbleTo, Reena serves as a passionate voice for the need to bridge the gaps between medical health and behavioral health. She spearheads AbleTo’s data analytics and outcomes research. Prior to her work at AbleTo, Dr. Pande was a cardiologist at Brigham and Women’s Hospital in Boston, MA and Instructor at Harvard Medical School. Reena Pande earned her undergraduate degree in Biology from Harvard University, her M.D. from Harvard Medical School, and a Masters degree in Epidemiology from the Harvard School of Public Health. She completed her internship, residency training, and fellowship in Cardiovascular Disease and Vascular Medicine at Brigham and Women’s Hospital.

Samir Malik Samir Malik is the Executive Vice President and General Manager of Genoa Telepsychiatry, a role he came into through the acquisition of the company he co-founded, 1DocWay. Prior to 1DocWay, Samir was the President of Signature Healthcare, and CEO of ZipCare Transportation. From 2010 to 2012, Samir was the Director of Strategic Planning at CenterPointe Hospital in St. Louis, Missouri, where he built a new model for outpatient mental health programs. Prior to CenterPointe Hospital, Samir’s career began with McKinsey & Co. Samir received his Bachelor of Science in Economics at Penn and his MBA at Wharton.

Corbin Petro Corbin Petro is the CEO and Co-Founder of Eleanor Health, the first addiction and mental health services provider designed to deliver long-term patient recovery outcomes and modeled on value-based care delivery and payments. Eleanor provides comprehensive, whole-person, tech-enabled services including medication, therapy, psychiatry, and peer coaching services for mental health and substance misuse in outpatient clinics, virtually, and in the community and patients’ homes. Previously, Petro was the founding CEO and President of Benevera Health, a first-of-its-kind payer/provider joint venture (JV) encompassing two businesses: Harvard Pilgrim Healthcare’s New Hampshire insurance business and a newly formed population health services company. Petro has an extensive background in healthcare including as Chief Operating Officer (COO) of the Massachusetts Department of Medicaid (MassHealth), a $13 billion agency providing health care to 1.4 million Massachusetts residents, advising a US Senator on health reform, and roles at Bain and Company, Goldman Sachs, Deloitte Consulting, and American Management Systems. Petro was honored as one of fifteen healthcare executives under 40 named a 2018 Up and Comer by Modern Healthcare. She received a BA from Yale University and an MBA from the Wharton School at the University of Pennsylvania. She is married, has two sons, and resides in the greater Boston area.

Danielle Lauzon Danielle Lauzon is a partner in Goodwin’s Technology Companies & Life Sciences group and leader of the firm’s Business Law Department in Boston. From 2007 through 2012, Ms. Lauzon was recognized as Massachusetts Super Lawyer “Rising Star” for her work representing private and public companies on general corporate and securities law and mergers and acquisitions. Ms. Lauzon also represents issuers in connection with the public offering and private placement of equity securities and has represented companies as well as venture capital and private equity firms in numerous venture capital financings and recapitalizations. Ms. Lauzon acts as co-chair of Goodwin’s PropSci practice, which is focused on supporting the intersection of real estate and life sciences, and currently serves on Goodwin’s Partnership Committee and on the Hiring Committee for the firm’s Boston office. She earned a JD from Villanova University School of Law and a BA from the University of Michigan.

CONTACT THE TEAM:

TOPIC SUGGESTIONS FOR FUTURE EPISODES:
Benjamin Lakin, PhD
Series Producer
Cambridge Healthtech Institute
Phone: 781-972-5454
Email: blakin@cambridgeinnovationinstitute.com

PARTNERING AND SPONSORSHIP:
Ilana Quigley
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: 781-972-5457
Email: iquigley@healthtech.com